chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient called on 04/16/2021 and stated that ever since she received the second dose of the moderna vaccine on 04/03/2021, she has been having pain in the arms, hips, thighs, and calves and feeling of muscle spasms.  the pain in the thighs and calves lasted about 24 hours, but eh pain in her arm, shoulder blades, and fingertips are still there. the pain feels like a dull, thrombing pain, and sometimes it hurts her to the point where she's not able to type.  she went to next level urgent care on 04/12/2021 and they gave her ibuprofen 800mg, but she's still having the pain.  she is scheduled to see her primary care physician on monday 4/19/2021.  upon further questioning her case, rph on duty found out she was cut by a chicken wire that was rusted on her left thumb and had received a tetanus vaccine on 03/20/2021 and was seen at an urgent care. rph on duty said she will follow up with patient on monday after she returns from seeing her md.
Employer offered flu shots to employees.  On 10-26-07 all employees interested had the shot.  Multiple employees have experienced continued aches/pains in the arm of the shot.  Personnally, if I lift my arm over shoulder height, I get a shooting pain in the area of the shot.  It has been almost three weeks. We spoke with two local nurses who said normally you could experience aches/pain in your arm for a couple of days but shouldn't last as long as three weeks.  Since multiple people have experienced the same thing, I can't help but think that maybe there was something wrong with the shot and/or the effectiveness of the shot.
Came to Mom felt sick to stomach had dry hives, then began shaking all over, blank stare, slow to respond to Mother, all occurred in 15 minutes, temp went from 99-103 during that 15 minutes. Mother took child to doctor 11/26/2014 and he said it was a vaccine reaction.
This is a spontaneous report by a contactable consumer (patient mother) through a Pfizer Sales Representative, and then from a contactable physician. A 15 months old female patient received the fourth dose of PREVNAR 13 single dose on 31Jan2014 as a part of the immunization. Vaccines given on the same day included unspecified vaccines on arm on 31Jan2014. The patient was previously administered with PREVNAR 13, single dose intramuscular injection on arm on an unknown date when she was 2 months old. Vaccines given within the last four weeks were none. On 02Feb2014 she experienced low grade fever, decreased appetite and had "red lump at the site of injection". She did not visit emergency room or was hospitalized because of the above mentioned events and she also did not report this events to her physician. Relevant therapeutic measures included TYLENOL for low grade fever. Relevant sibling information was none. Relevant lab data was none. The patient recovered from the above mentioned events in Feb2014. The reporting physician did not confirm the occurrence of the events reported by the patient. Follow-up (19Feb2014): New information received from a contactable physician includes: the reporting physician did not confirm the occurrence of the events reported by the patient. Follow-up attempts completed. No further information expected.
pt recvd vax; exp dizziness, cramping, d; 2 days later malaise, yeast infect, itching vaginal severe; HA;
RD red/swollen 5 1/2cm X 5 1/2cm.
From initial information received on 2/12/03 from MIS, it was reported that a 46 year old male patient experienced an Arthus reaction after receiving a Td injection in his right deltoid on 1/30/03. The patient was seen on 2/11/03. The patient complained of fever of 103F and soreness with myalgia and fatigue, erythema and tenderness to touch. The patient took Tylenol for headache and fever and was given Duracef. The patient was to have followed up with his doctor on 2/13/03. Recovery status is unknown at this time.
3 inch lesion. Red, swollen, hot and painful. Grew ins ice over 48 hours.
Night of the vaccine- sore/tender arm with minimal redness lasted about 24 hours.  8 days later- covid arm- site of injection turned red and felt like a knot with a little bit of itchiness. lasted approx 2 days
Complaint of cough, sore/scratchy throat, headache, runny nose/congestion and myalgia.
Swelling, warm to touch, itching arm, hives to arm, to ER 4 days after vaccine.
sensation of bubbles on the blood vessels of the leg, that later extended to the arm and hand.; pain at the site of the injection (upper right arm); This spontaneous case was reported by a consumer and describes the occurrence of AIR EMBOLISM (sensation of bubbles on the blood vessels of the leg, that later extended to the arm and hand.) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Aug-2021, the patient experienced AIR EMBOLISM (sensation of bubbles on the blood vessels of the leg, that later extended to the arm and hand.) (seriousness criterion medically significant) and VACCINATION SITE PAIN (pain at the site of the injection (upper right arm)). At the time of the report, AIR EMBOLISM (sensation of bubbles on the blood vessels of the leg, that later extended to the arm and hand.) and VACCINATION SITE PAIN (pain at the site of the injection (upper right arm)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided  Treatment information included ashubanda to try and alleviate the symptoms.  Company Comment: This case concerns a 43-year-old patient of an unknown gender, who experienced the unexpected event of Air embolism, and expected event of Vaccination site pain. The events occurred approximately 8 days after the first dose of mRNA-1273 (Moderna COVID-19 Vaccine). The event Vaccination site pain is consistent with the known safety profile. The benefit-risk relationship of drug mRNA-1273 (Moderna COVID-19 Vaccine) in not affected by this report.; Sender's Comments: This case concerns a 43-year-old patient of an unknown gender, who experienced the unexpected event of Air embolism, and expected event of Vaccination site pain. The events occurred approximately 8 days after the first dose of mRNA-1273 (Moderna COVID-19 Vaccine). The event Vaccination site pain is consistent with the known safety profile. The benefit-risk relationship of drug mRNA-1273 (Moderna COVID-19 Vaccine) in not affected by this report.
hotness; light fever; headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hotness), PYREXIA (light fever), HEADACHE (headache) and CHILLS (Chills) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 13-Jan-2021, the patient experienced FEELING HOT (hotness), PYREXIA (light fever), HEADACHE (headache) and CHILLS (Chills). At the time of the report, FEELING HOT (hotness), PYREXIA (light fever), HEADACHE (headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information provided included paracetamol to treat symptoms.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
red, inflamed, painful circular marking at injection site. it started about a quarter in size and grew to about the size of a softball. the marking lasted about 1 week then went away all at once, not in a shrinking fashion
Pt vax /w DT/OPV/HIB 5 days /p vaccination, pt developed erythema multiforme and serum sickness with migratory polyarithritis, which lasted for 6 weeks.
Approximately 1 hour after receiving injection the patience arm swelled, started running fever of 102 and nausea/vomiting occurred. Patient seeked treatment. received medication. Patient states that as of 10/4/2017 her arm is still swollen.
Chills; fatigue; muscle aches; body ache; did not feel like myself after this first injection; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL8982), via an unspecified route of administration on 15Mar2021 at 08:30 (at the age 67-years-old), as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation. The patient had no allergies to medications, food, or other products. Concomitant medications included diltiazem (CARDIZEM) and apixaban (ELIQUIS); both for unspecified indication from unknown date. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021, about 4 to 6 hours after the vaccination, the patient experienced chills, fatigue, muscle aches, body aches. The patient did not feel like himself. The patient had been known to have a very good immune system. The second dose was due on 05Apr2021 (as reported). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of chills, fatigue, muscle aches, body aches and feeling abnormal was recovered on an unspecified date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Expired dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 15-month-old female patient who received DTPa (Infanrix) (batch number 7KM94, expiry date 10-JUN-2023) for prophylaxis.   On 12-JUN-2023, the patient received Infanrix. On 12-JUN-2023, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: Expired dose administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 12-Jun-2023 The vaccine administration facility was the same as primary reporter.  The reporter consented to follow-up via email. The patient received an expired dose of Infanrix, which led to expired vaccine used.
PATIENT DID NOT HAVE AN ADVERSE REACTION AT THIS TIME BUT HE WAS GIVEN A VACCINE THAT EXPIRED ON 2/27/2021
positive COVID-19 test; positive COVID-19 test; This is a spontaneous report from a contactable consumer who reported for his father. A 79-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection) via an unspecified route of administration on 21Jan2021 (also reported as 24Jan2021) (at the age of 79-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. It was reported that the patient received the first dose of the Pfizer COVID-19 vaccine and had since tested positive. The reporter stated that his dad got the vaccine on 21Jan2021 and got COVID-19 but got the first dose only. The patient had recovered and was coming back from the hospital, he was not critical. The patient was scheduled to get his second vaccine on 11Feb2021 but was getting over treatment. The reporter inquired whether the patient could get the second dose. He stated that he had heard that he had to wait 90 days after COVID and asked whether he should get the second vaccine now. The clinical outcome of the event positive COVID-19 test was recovered/resolved on an unspecified date.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Had multiple eye rolling upward episodes that appeared to be seizures; Indurated; Large bruise at site of injection; Petechiae; Rash on arms, legs, and trunk; Patient under 4 years of age received Influenza; Information has been downloaded from regulatory authority (US-CHIRONMA-PHHY2015US047488).   This spontaneous report was received from an other healthcare professional and refers to a 1-year-old male patient. There was no information about the patient's concurrent conditions, concomitant medications and medical history provided.   On 08-DEC-2014, the patient was vaccinated with hepatitis a vaccine, inactivated (manufacturer unknown), 1 dosage form (exact date, route of administration, anatomical location, lot # and expiration date were not reported). On the same day the patient also received measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown), 1 dosage form (exact date, route of administration, anatomical location, lot # and expiration date were not reported), varicella virus vaccine live (oka/merck)(manufacturer unknown), 1 dosage form (exact date, route of administration, anatomical location, lot # and expiration date were not reported), diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid; 1 dosage form (exact date, route of administration, anatomical location, lot # and expiration date were not reported) and unspecified influenza virus vaccine, 1 dosage form (DF) (exact date, route of administration, anatomical location, lot # and expiration date were not reported). The reporter informed, that the influenza vaccine should not be administered to the patient under 4 years of age (drug use in unapproved population). All the vaccines were administered for immunization.   On 24-DEC-2014, the patient experienced multiple episodes of eye rolling upward that appeared to be seizures, petechiae, vaccination site induration (reported as indurated) and had a large bruise at the injection site and rash on his arms, legs and trunk. Additionally, the reporter informed that on an unknown date the patient had electroencephalogram (EEG) with the result reported as normal. The outcome of the events was unknown.  The relatedness between the event of multiple eye rolling upward episodes that appeared to be seizures and unspecified influenza virus vaccine was reported as suspected. The relatedness between the events of vaccination site induration, large bruise at site of injection, drug use in unapproved population, petechiae, rash and unspecified influenza virus vaccine were reported as not assessable. The causality assessment between the events and the other suspect therapies was not provided by the reporter.   The Agency considered all the events to be medically significant.
a little left arm soreness from the needle; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (a little left arm soreness from the needle) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 027L02A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Blood pressure high and Hypercholesterolemia (high cholesterol).   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (a little left arm soreness from the needle). At the time of the report, VACCINATION SITE PAIN (a little left arm soreness from the needle) outcome was unknown.            Concomitant medications include many medications for diabetes, high blood pressure and high cholesterol. Treatment information was not provided.   This case was linked to MOD-2021-434957 (Patient Link).
Patient admitted with hypoxia and pulmonary emboli. She was started on heparin, has now obtained Eliquis, and home O2 has been arranged. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
pt presented to office 20APR98 w/vesicular lesions compatible to chickenpox;no fever;no other sx noted;mild case;
Vaccine administered on 10/13/08, in Left thigh, on 10/15/08 MOC brought baby to clinic because he had developed a fluid filled blister on the outer aspect of the left thigh, approx 1 cm in length, 1mm in width.  Vaccine was given on the front of the thigh approx 2 inchies from the blister.
Patient received vaccine and within 5 minutes was not feeling well. Patient fainted and then when conscious began vomiting. Patient also became very pale and clammy. Patient has experienced vasovagal symptoms before when having blood work done but not during vaccination. Patient also stated afterwards that she had not eaten any food all morning prior to receiving the vaccine.
On January 30, 2018 got a flu shot by Dr. That night I noticed that my arm was sore and very stiff. I didn't think anything of it because in the past whenever I've gotten flu shots my arm was sore for a few days, which is perfectly normal. The problem I'm having is that the stiff arm is now followed by pain and burning sensation to this day. I saw Dr. two weeks after getting the flu shot to let him know. He examined my arm and said, pain the arm from a shot is common. He sent me for physical therapy. I started last week. My physical therapist has scheduled me for 10 sessions. In the past I've gotten flu shots and never had this kind of reaction. Yes, my arm is sore for a few days, but then it goes away and my arm feels fine. This time, my arm feels like it's been injured some how. I can move it up to a certain point, when I go beyond a certain point, I feel my arm very stiff followed by pain and burning sensation. I am very worried that my arm will never be the same again. Not sure what to do at this point.
Participant experienced swelling after vaccination/no epi administered/participant stated they had history of allergies and would self-medicate with Benadryl.
severe pain in big toe & ball of foot lt foot;h/a x 7 days;general flu like weak feeling;
Pt woke up with redness, warmth and raised across back area-took BENADRYL-Pt. called to be checked today 3-10-15. Left arm has raised wheal 1/2 x 1/2 and 5 1/2 x 3"-Right arm has 1/2 x 1/2-wheal and 6" x 3" - erythema-Both warm to touch.
This spontaneous report as received from a medical assistant refers to a female patient of unknown age. On 30-JUL-2010, the patient was vaccinated with first dose of GARDASIL dose 0.5 ml, intramuscular (anatomical location was not reported). On 09-SEP-2010, the patient was vaccinated with second dose of GARDASIL dose 0.5 ml, intramuscular (anatomical location was not reported). On 29-AUG-2011 the patient was vaccinated with the third dose of GARDASIL dose 0.5 ml, intramuscular (anatomical location was not reported). On 23-OCT-2014 the patient inadvertently was vaccinated with fourth dose of GARDASIL dose 0.5 ml, intramuscular (anatomical location was not reported). There was no adverse experience reported. Additional information has been requested.
Information has been received from a physician concerning a 31 year old female who was vaccinated with Gardasil. Subsequently the patient developed a severe rash. The patient was vaccinated in the biceps and possibly subcutaneouusly. The patient was not given a second dose to the previous rash. As of 20-MAR-2007, the patient was recovering from the severe rash. The patient sought unspecified medical attention. Additional information has been requested. This is in follow-up to report (s) previously submitted on 4/13/2007.
Information has been received from a licensed practical nurse concerning a 24 year old female who on approximately 18-JUN-2007 was vaccinated IM with a third 0.5 ml dose of Gardasil (lot# 657868/0523U). Concomitant therapy included medroxyprogesterone acetate (DEPO-PROVERA). On 18-JUN-2007, the patient experienced redness and a rash at the injection site. Unspecified medical attention was sought. No diagnostic laboratory studies were performed. On 18-JUN-2007, the patient recovered. No product quality complaint was involved. Additional information has been requested.
Possible stroke, violent shaking that does not stop. She is bed ridden and cannot speak. The 2nd shot magnified her Parkinson's issues. She is on her death bed.
Patient woke up with a red inflamed arm where the Pneumovax immunization was injected.
1130 Patient received an extra dose of Varicella. No adverse outcomes noted after vaccine administration
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 53-year-old male patient received BNT162b2 (BNT162B2), on 29Sep2021 at 12:00 as dose 3 (booster), single (Lot number: 301708A) at the age of 53 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "DM" (unspecified if ongoing), notes: other medical history: DM; "HTN" (unspecified if ongoing), notes: other medical history: HTN; "hypothyroid" (unspecified if ongoing), notes: other medical history: hypothyroid; "GERD" (unspecified if ongoing), notes: other medical history: GERD; "insomnia" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Bactrim, reaction(s): "Known Allergy: Bactrim", notes: Known Allergy: Bactrim; Lisinopril, reaction(s): "Known Allergy: Lisinopril", notes: Known Allergy: Lisinopril. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on plausible dose -event relationship post vaccination and no other alternate explanation the causal role of BNT162B2 cannot be excluded for the reported LOE events.
Patient was sat in the front of the pharmacy to wait 15 min after vaccination. Patient agent with him came to the counter and stated patient was not feeling well. Patient was pale, sweating, and feeling nauseous. After 3 minutes (approximately 8 minutes after vaccination), patient started to vomit on himself and was given a basket. Gave Ice pack to place on neck, shoulder, and head  and gave cold wet cloth to clean up vomit. Proceded to make patient wait an additional 15 minutes and patient started to feel better and was given okay to leave.
chills; upset stomach; This is a spontaneous report from a contactable consumer or other non-health care professional (patient).  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration on 22Feb2021 as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. Medical history and concomitant medications were not reported. On 23Feb2021, the patient experienced chills and upset stomach. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
A day after first vaccine, ringing in ears developed ( tinnitus) still has not resolved . Also had heart palpitations and excessive dizziness with high blood pressure that lasted for 5 hours.